Fluoride Pharmacokinetics in Urine and Plasma Following Multiple Doses of MK‐8507, an Investigational, Oral, Once‐Weekly Nonnucleoside Reverse Transcriptase Inhibitor-Reference-Cited by-同舟云学术

Fluoride Pharmacokinetics in Urine and Plasma Following Multiple Doses of MK‐8507, an Investigational, Oral, Once‐Weekly Nonnucleoside Reverse Transcriptase Inhibitor

Published:2021-11-12 Issue:2 Volume:62 Page:199-205
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharma

Author:

Gillespie Gillian¹,Jackson Rudd Deanne¹,Zhang Saijuan¹,Schaeffer Andrea¹,Tomek Charles²,Larson Patrick¹,Stoch S. Aubrey¹,Iwamoto Marian¹

Affiliation:

1. Merck & Co, Inc. Kenilworth New Jersey USA

2. Celerion Lincoln Nebraska USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1957

Reference16 articles.

1. AnkromW SchurmannD Jackson RuddD et al.Single doses of MK‐8507 a novel HIV‐1 NNRTI reduced HIV viral load for at least a week. Oral O416. Presented at: HIV Glasgow; October 5–8 2020(virtual event).

2. AnkromW SchaefferA PanebiancoD et al.Safety tolerability and pharmacokinetics following single‐ and multiple‐dose administration of the novel NNRTI MK‐8507 with a midazolam interaction arm. Poster presented at: HIV Glasgow; October 5–8 2020(virtual event). Poster P099.

3. Position of the Academy of Nutrition and Dietetics: The Impact of Fluoride on Health

4. Fluoride

5. The Fluoride Debate: The Pros and Cons of Fluoridation

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approved HIV reverse transcriptase inhibitors in the past decade;Acta Pharmaceutica Sinica B;2021-11